Alector LLC, Rosenthal's latest venture zeroing in on a treatment for dementia and Alzheimer's disease, closed a Series A round aimed at identifying two drugs within the next two years that can be prepped for human clinical trials.
Alector didn't say how much was invested in the round led by Polaris Venture Partners and OrbiMed Advisors, and Rosenthal wouldn't say more about the pathway that Alector is targeting for its treatments. But the co-founder? (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
phlebotomy classes online phlebotomy training nyc phlebotomy training in nyc
No comments:
Post a Comment